Dolby Laboratories Stockholders Approve Directors, Pay and Auditor
TipRanks (Fri, 6-Feb 4:56 PM ET)
Source-Connect 4 Becomes First metadata-connected Dolby Atmos remote review & approval tool
PRNewswire (Tue, 3-Feb 3:11 AM ET)
Dolby Laboratories Reports First Quarter 2026 Financial Results
PRNewswire (Thu, 29-Jan 4:15 PM ET)
Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2026 Financial Results
PRNewswire (Tue, 13-Jan 4:15 PM ET)
Dolby Sets the New Standard for Premium Entertainment at CES 2026
PRNewswire (Tue, 6-Jan 8:30 AM ET)
PRNewswire (Mon, 5-Jan 9:30 PM ET)
PRNewswire (Thu, 18-Dec 8:30 AM ET)
PRNewswire (Wed, 17-Dec 8:00 PM ET)
PRNewswire (Wed, 3-Dec 8:30 AM ET)
BAY AREA HOST COMMITTEE AND DOLBY PARTNER TO DELIVER IMMERSIVE FAN EXPERIENCES
PRNewswire (Wed, 19-Nov 11:00 AM ET)
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
Dolby Laboratories trades on the NYSE stock market under the symbol DLB.
As of February 10, 2026, DLB stock price climbed to $68.19 with 949,370 million shares trading.
DLB has a beta of 0.76, meaning it tends to be less sensitive to market movements. DLB has a correlation of 0.40 to the broad based SPY ETF.
DLB has a market cap of $6.51 billion. This is considered a Mid Cap stock.
Last quarter Dolby Laboratories reported $347 million in Revenue and $1.06 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.22.
In the last 3 years, DLB traded as high as $91.02 and as low as $60.14.
The top ETF exchange traded funds that DLB belongs to (by Net Assets): IJH, VTI, VGT, VB, SDVY.
DLB has underperformed the market in the last year with a return of -17.1%, while SPY returned +16.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in DLB shares. However, DLB has outperformed the market in the last 3 month and 2 week periods, returning +5.3% and +9.8%, while SPY returned +3.4% and -0.1%, respectively. This indicates DLB has been having a stronger performance recently.
DLB support price is $65.12 and resistance is $67.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DLB shares will trade within this expected range on the day.